T 0370/11 of 19.08.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T037011.20140819
- Date of decision
- 19 August 2014
- Case number
- T 0370/11
- Petition for review of
- -
- Application number
- 03796701.5
- IPC class
- A61P 43/00A61K 31/444A61P 11/00A61P 37/00A61K 31/454A61P 1/00A61P 29/00A61P 9/00A61P 33/00A61P 15/00A61P 31/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- INHIBITION OF INFLAMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS
- Applicant name
- The Feinstein Institute for Medical Research
- Opponent name
- AstraZeneca AB
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 101(1)European Patent Convention R 103(2)
- Keywords
- Reimbursement of appeal fee (partly) - withdrawal of patent proprietor's appeal
Admissibility of opponent's appeal (no) - missing statement of grounds - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. 50% of the appeal fee paid by the patent proprietor is to be reimbursed.
2. The appeal filed by the opponent is rejected as inadmissible.